BVT Aktienanleihe AMD 27.06.2025/ DE000VD5TM52 /
2025-04-30 8:49:36 AM | Chg.-1.02 | Bid10:00:10 PM | Ask10:00:10 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
70.11EUR | -1.43% | - Bid Size: - |
- Ask Size: - |
Advanced Micro Devic... | 140.00 USD | 2025-06-27 | Call |
GlobeNewswire
1:05 PM
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
GlobeNewswire
10:00 AM
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conference...
GlobeNewswire
04-30
Valitor to Present on its Drug Candidate with Twice-Yearly Dosing for Wet AMD at the American Academ...
GlobeNewswire
04-29
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmolog...
GlobeNewswire
04-29
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
04-28
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy...
GlobeNewswire
04-24
Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision a...
GlobeNewswire
04-18
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License A...
GlobeNewswire
04-17
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment ...
GlobeNewswire
04-15
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
GlobeNewswire
04-15
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pip...
GlobeNewswire
04-09
5th Gen AMD EPYC Processors Deliver Leadership Performance for Google Cloud C4D and H4D Virtual Mach...